ArticlePsychiatric bulletin (2014)2014
Unheard voices: outcomes of tertiary care for treatment-refractory psychosis.
Article in Psychiatric bulletin (2014), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Developing prediction models for symptom severity around the time of discharge from a tertiary-care program for treatment-resistant psychosis.Frontiers in psychiatry · 2023Article
- Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations.Therapeutic advances in psychopharmacology · 2021Article
- Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study.BJPsych open · 2020Article
- Unheard voices: outcomes of tertiary care for treatment-refractory psychosis - ADDENDUM.BJPsych bulletin · 2019Article
- Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.PloS one · 2018Article
- In-patient rehabilitation: clinical outcomes and cost implications.BJPsych bulletin · 2016Article
- Optimising plasma levels of clozapine during metabolic interactions: a review and case report with adjunct rifampicin treatment.BMC psychiatry · 2015Review
- Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia.BMC psychiatry · 2015Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Aims and method In up to a quarter of patients, schizophrenia is resistant to standard treatments. We undertook a naturalistic study of 153 patients treated in the tertiary referral in-patient unit of the National Psychosis Service based at the Maudsley Hospital in London. A retrospective analysis of symptoms on admission and discharge was undertaken using the OPCRIT tool, along with preliminary economic modelling of potential costs related to changes in accommodation. Results In-patient treatment demonstrated statistically significant improvements in all symptom categories in patients already identified as having schizophrenia refractory to standard secondary care. The preliminary cost analysis showed net savings to referring authorities due to changes from pre- to post-discharge accommodation. Clinical implications Despite the enormous clinical, personal and societal burden of refractory psychotic illnesses, there is insufficient information on the outcomes of specialised tertiary-level care. Our pilot data support its utility in all domains measured.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.